US Patent 11230588 CD80 variant immunomodulatory proteins and uses thereof
Patent 11230588 was granted and assigned to ALPINE IMMUNE SCIENCES, INC. on January, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11230588 CD80 variant immunomodulatory proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.